Stocks and Investing
Stocks and Investing
Tue, May 2, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Suraj Kalia Maintained (TMDX) at Buy with Increased Target to $90 on, May 2nd, 2023
Suraj Kalia of Oppenheimer, Maintained "TransMedics Group, Inc." (TMDX) at Buy with Increased Target from $85 to $90 on, May 2nd, 2023.
Suraj has made no other calls on TMDX in the last 4 months.
There are 4 other peers that have a rating on TMDX. Out of the 4 peers that are also analyzing TMDX, 1 agrees with Suraj's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $74 on, Thursday, February 23rd, 2023
These are the ratings of the 3 analyists that currently disagree with Suraj
- Joshua Jennings of "Cowen & Co." Maintained at Buy with Increased Target to $75 on, Thursday, February 23rd, 2023
- Thomas Allen of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Thursday, February 23rd, 2023
- William Plovanic of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $78 on, Thursday, February 23rd, 2023
Contributing Sources